0O2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sagimet Biosciences Inc

Watchlist Manager

Watchlist

Price: 9.42 EUR 3.06% Market Closed

Market Cap: €306.3m

	Sagimet Biosciences Inc F:0O2	US
S	Sekisui House Ltd SWB:SPH1	JP
E	Edgewell Personal Care Co XMUN:EGZ	US
	SK Inc KRX:03473K	KR
	Naturgy Energy Group SA F:GANA	ES
	Bentley Systems Inc F:BS81	US
	PTC Therapeutics Inc F:BH3	US
	Exlservice Holdings Inc NASDAQ:EXLS	US
P	Pop Mart International Group Ltd F:735	CN
	Brookfield Wealth Solutions Ltd TSX:BNT	BM
	Brookfield Wealth Solutions Ltd F:9JG	BM

Profitability Summary

Sagimet Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-1 513%

Low Net Margin

Negative 3Y Average Net Margin

-1 310%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1 248%

Negative ROE

-24%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

404%

ROIC is Increasing

-1 530% > -326%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.